Figure 4From: Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials Free and Total oncostatin M in one patient following repeating dosing with GSK315234. Back to article page